Related Experiment Video
Updated: Jun 17, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Ginsenoside Re inhibits non-small cell lung cancer progression by suppressing macrophage M2 polarization induced by
Xiaoyu Tang1,2, Man Zhu1,2, Zeren Zhu1,2
1School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, People's Republic of China.
Abstract:
Tumor-associated macrophages (TAMs) in non-small cell lung cancer (NSCLC) promote tumor cell metastasis by interacting with cancer cells. Ginsenoside Re is capable of modulating the host immune system and exerts anticancer effects through multiple pathways. Both AMPK and STING are involved in the regulation of MΦ polarization, thereby affecting tumor progression. However, whether there is a regulatory relationship between them and its effect on MΦ polarization and tumor progression is unclear. The aim of this study was to provide mechanistic evidence that ginsenoside Re modulates MΦ phenotype through inhibition of the AMPKα1/STING positive feedback loop and thus exerts an antimetastatic effect in NSCLC immunotherapy. Cell culture models and conditioned media (CM) systems were constructed, and the treated MΦ were analyzed by database analysis, RT-PCR, Western blotting, flow cytometry, and immunofluorescence to determine the regulatory relationship between AMPK and STING and the effects of ginsenoside Re on MΦ polarization and tumor cells migration. The effects of ginsenoside Re (10, 20 mg/kg/day) on TAMs phenotype as well as tumor progression in mice were assessed by HE staining, immunohistochemical staining, and Western blotting. In this study, AMPKα1/STING positive feedback loop in NSCLC TAMs induced M2 type polarization, which in turn promoted NSCLC cell migration. In addition, ginsenoside Re was discovered to inhibit M2-like MΦ polarization, thereby inhibiting NSCLC cell migration. Mechanistically, Re was able to inhibit the formation of the AMPKα1/STING positive feedback loop, thereby inhibiting its induction of M2-like MΦ and consequently inhibiting the epithelial-mesenchymal transition (EMT) process of NSCLC cells. Furthermore, in mouse models, Re was found to suppress LLC tumor growth and colonization by inhibiting M2-type polarization of TAMs. Our finding indicates that ginsenoside Re can effectively modulate MΦ polarization and thus play an important role in antimetastatic immunotherapy of NSCLC.
Insights
Ginsenoside Re inhibits the AMPKα1/STING feedback loop in non-small cell lung cancer (NSCLC) macrophages, reducing M2 polarization and metastasis. This study reveals a novel therapeutic strategy for NSCLC immunotherapy.
Area of Science:
- Immunology
- Oncology
- Pharmacology
Background:
- Tumor-associated macrophages (TAMs) in non-small cell lung cancer (NSCLC) promote metastasis.
- Ginsenoside Re exhibits anticancer properties by modulating the immune system.
- AMP-activated protein kinase (AMPK) and Sting (STING) pathway regulate macrophage polarization and tumor progression.
Purpose of the Study:
- To investigate the regulatory relationship between AMPK and STING in NSCLC TAMs.
- To elucidate the mechanism by which ginsenoside Re affects MΦ polarization and NSCLC metastasis.
- To provide mechanistic evidence for ginsenoside Re's antimetastatic effects in NSCLC immunotherapy.
Main Methods:
- Constructed cell culture and conditioned media (CM) systems.
- Utilized RT-PCR, Western blotting, flow cytometry, and immunofluorescence to analyze MΦ polarization.
- Assessed ginsenoside Re's effects on TAM phenotype and tumor progression in mouse models.
Main Results:
- Identified an AMPKα1/STING positive feedback loop in NSCLC TAMs that drives M2 polarization and promotes NSCLC cell migration.
- Demonstrated that ginsenoside Re inhibits M2-like MΦ polarization by disrupting the AMPKα1/STING feedback loop.
- Showed that ginsenoside Re inhibits NSCLC cell migration and epithelial-mesenchymal transition (EMT) in vitro and suppresses tumor growth in vivo.
Conclusions:
- Ginsenoside Re effectively modulates MΦ polarization by inhibiting the AMPKα1/STING positive feedback loop.
- Ginsenoside Re exhibits significant antimetastatic effects in NSCLC.
- Ginsenoside Re holds potential as a therapeutic agent for NSCLC immunotherapy.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

